The case involves Germany's Boehringer Ingelheim Pharma GmbH & Co, which claimed a drug named linagliptin used to treat diabetes is patented. It approached the court in 2020, citing a news article that Cadila Healthcare Ltd and West Coast Pharmaceutical Works Ltd had got a tentative licence to export the drug and received permission from the United States Food & Drug Administration (USFDA) for the same.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/BD2Cmoc
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Pharmaceutical companies restrained from making diabetes drug
https://ift.tt/iD4nH2K
No comments:
Post a Comment